These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3161364)

  • 1. [Comparative analysis of methods of the immunotherapy of spontaneous abortions].
    Govallo VI; Bykova EIa; Kal'ke IK
    Akush Ginekol (Mosk); 1985 Mar; (3):41-3. PubMed ID: 3161364
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical observation of lymphocyte active immunotherapy in 380 patients with unexplained recurrent spontaneous abortion.
    Chen JL; Yang JM; Huang YZ; Li Y
    Int Immunopharmacol; 2016 Nov; 40():347-350. PubMed ID: 27673476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of patients with recurrent spontaneous miscarriage and idiopathic infertility: does the immunization-dependent Th2 cytokine overbalance really matter?
    Wilczyński JR; Radwan P; Tchórzewski H; Banasik M
    Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):151-60. PubMed ID: 22349103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial comparing expectant with medical management for first trimester miscarriages.
    Ahmed AA; Steel S
    BJOG; 2000 Mar; 107(3):435-6. PubMed ID: 10740349
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse influence of numbers of previous miscarriages on results of paternal lymphocyte immunization in patients with recurrent spontaneous abortions.
    Katano K; Aoki K; Ogasawara MS; Suzumori K
    Am J Reprod Immunol; 2000 Nov; 44(5):289-92. PubMed ID: 11125791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of habitual abortion by vaccinating women with the husband's lymphocytes].
    Uhrynowska M; Zupańska B
    Ginekol Pol; 1989 Feb; 60(2):132. PubMed ID: 2806963
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognosis and treatment of threatened abortion. A. Prognostic value of maternal serum determination of choriogonadotropin and its free alpha and beta subunits in threatened abortion of the first trimester: correlation with ultrasonographic examination].
    Gaspard U; Schaaps JP; Piront F; Deville JL; Reuter AM; Vrindts-Gevaert Y; Franchimont P
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):62-6. PubMed ID: 7451883
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological characteristics of women with an interrupted pregnancy of unexplained etiology].
    Kovalenko VV; Mal'chenko ID; Tsareva NA
    Pediatr Akus Ginekol; 1977; (2):41-3. PubMed ID: 882324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunomodulating therapy in various complications of the gestational period].
    Nazarenko LG
    Akush Ginekol (Mosk); 1990 Nov; (11):12-5. PubMed ID: 2127654
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerclage of the cervical canal in cervix insufficiency with prolapsed amnion].
    Radulovic B; Marinkovic P; Pavicevic P
    Srp Arh Celok Lek; 1973 Jan; 101(1):13-8. PubMed ID: 4786455
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of abortion].
    Vasil'eva OIu
    Feldsher Akush; 1987 Oct; 52(10):13-9. PubMed ID: 3436444
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of first trimester miscarriage by general practitioners in Ireland.
    Prendiville W; O'Kelly F; Allwright S; McGuinness N
    Ir J Med Sci; 1997; 166(1):3-6. PubMed ID: 9057421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of anti-beta2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester.
    Mezzesimi A; Florio P; Reis FM; D'Aniello G; Sabatini L; Razzi S; Fineschi D; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):164-8. PubMed ID: 17046145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Considerations on the use of a new orally active artificial progestinic agent in threatened abortions in the first trimester of pregnancy. Clinical study].
    CANTALUPPI G
    Minerva Ginecol; 1962 May; 14():475-8. PubMed ID: 13876252
    [No Abstract]   [Full Text] [Related]  

  • 15. Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age.
    Lambropoulou M; Tamiolakis D; Venizelos J; Liberis V; Galazios G; Tsikouras P; Karamanidis D; Petrakis G; Constantinidis T; Menegaki M; Papadopoulos N
    Clin Exp Med; 2006 Dec; 6(4):171-6. PubMed ID: 17191109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female third party lymphocytes are effective for immunotherapy of patients with unexplained primary recurrent spontaneous abortion: A retrospective analysis of outcomes.
    Liang X; Qiu T; Qiu L; Wang X; Zhao A; Lin Q
    Eur J Contracept Reprod Health Care; 2015; 20(6):428-37. PubMed ID: 25985825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous abortion.
    McBride WZ
    Am Fam Physician; 1991 Jan; 43(1):175-82. PubMed ID: 1986486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-D immunoglobulin for bleeding in early pregnancy.
    Everett CB
    BMJ; 1990 Dec; 301(6764):1329. PubMed ID: 2176906
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of first trimester spontaneous abortions.
    Forbes K
    BMJ; 1995 Jun; 310(6992):1426. PubMed ID: 7613270
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical laboratory research on habitual abortions of presumed immune origin].
    Despodova Ts; Rusev R
    Akush Ginekol (Sofiia); 1988; 27(3):14-8. PubMed ID: 3052129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.